Law360, New York (January 14, 2015, 1:37 PM EST) -- Gaby L. Longsworth, Ph.D., is a director in the biotechnology and chemical group at Sterne Kessler Goldstein & Fox PLLC, an intellectual property law firm in Washington, D.C. Dr. Longsworth advises both innovator and generic biotech and pharmaceutical companies on IP and product lifecycle management strategies. A large part of her practice is focused on representing international and domestic generic pharmaceutical companies in patent cases involving abbreviated new drug applications that include a Paragraph IV certification to one or more Orange Book-listed patents. She also uses her generic drug experience to counsel innovator pharmaceutical companies throughout the world in all areas of patent procurement, including domestic and foreign patent preparation, and lifecycle management strategies....